Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse model
Masaki Imanishi(Tokushima University Hospital), Keisuke Ishizawa(Tokushima University Hospital), Akiko Maegawa(Tokushima University), Yoshito Zamami(Tokushima University Hospital), Yusuke Yamakawa(Tokushima University Hospital), Keijo Fukushima(Tokushima University), Koichiro Tsuchiya(Tokushima University), Masatoshi Kishuku(Tokushima University Hospital), Mitsuhiro Goda(Okayama University), Raiki Ikuto(Tokushima University), Yuki Izawa‐Ishizawa(Shikoku University), Yasumasa Ikeda(Tokushima University), Yuya Horinouchi(Tokushima University), Masayuki Chuma(Nihon University), Hiromichi Fujino(Tokushima University), Koichi Tsuneyama(Tokushima University), Masateru Kondo(Tokushima University Hospital), Kenshi Takechi(Matsuyama University)
Cited by 4
Related Papers
Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasia
|Journal of Autoimmunity|2008|151
Estrogen Regulates Hepcidin Expression via GPR30-BMP6-Dependent Signaling in Hepatocytes
|PLoS ONE|2012|138
Factors Associated With Immune Checkpoint Inhibitor–Related Myocarditis
|JAMA Oncology|2019|134
Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis
|Hepatology|2011|124
Activation of FP Prostanoid Receptor Isoforms Leads to Rho-mediated Changes in Cell Morphology and in the Cell Cytoskeleton
|Journal of Biological Chemistry|1999|114